Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 2
2016 3
2017 4
2018 2
2019 1
2020 1
2021 1
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis.
Martínez Rivera C, Crespo-Lessmann A, Arismendi E, Muñoz-Esquerre M, Aguilar X, Ausín P, Bobolea I, Dalmau Duch G, Pifarre Teixido R, Sabater Talaverano G, Sogo Sabardía A, Gall XM. Martínez Rivera C, et al. Among authors: munoz esquerre m. J Asthma. 2022 Jun;59(6):1195-1202. doi: 10.1080/02770903.2021.1917605. Epub 2021 May 8. J Asthma. 2022. PMID: 33882776
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome.
Pérez de Llano L, Dacal Rivas D, Marina Malanda N, Plaza Moral V, Gullón Blanco JA, Muñoz-Esquerre M, García-Moguel I, Díaz Campos RM, Martínez-Moragón E, Harbenau Mena A, Cosío BG, Padilla Galo A, Cisneros Serrano C. Pérez de Llano L, et al. Among authors: munoz esquerre m. J Asthma Allergy. 2022 Mar 18;15:363-369. doi: 10.2147/JAA.S338467. eCollection 2022. J Asthma Allergy. 2022. PMID: 35330786 Free PMC article.
Sudan red dye: a new agent causing type-2 occupational asthma.
Clofent D, de Homdedeu M, Muñoz-Esquerre M, Cruz MJ, Muñoz X. Clofent D, et al. Among authors: munoz esquerre m. Allergy Asthma Clin Immunol. 2020 Jan 30;16:7. doi: 10.1186/s13223-020-0404-8. eCollection 2020. Allergy Asthma Clin Immunol. 2020. PMID: 32021623 Free PMC article.
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both.
Pfeffer PE, Ali N, Murray R, Ulrik C, Tran TN, Maspero J, Peters M, Christoff GC, Sadatsafavi M, Torres-Duque CA, Altraja A, Lehtimäki L, Papadopoulos NG, Salvi S, Costello RW, Cushen B, Heffler E, Iwanaga T, Al-Ahmad M, Larenas-Linnemann D, Kuna P, Fonseca JA, Al-Lehebi R, Rhee CK, Perez-de-Llano L, Perng Steve DW, Mahboub B, Wang E, Goh C, Lyu J, Newell A, Alacqua M, Belevskiy AS, Bhutani M, Bjermer L, Bjornsdottir U, Bourdin A, Bulow AV, Busby J, Canonica GW, Cosio BG, Dorscheid DR, Muñoz-Esquerre M, FitzGerald JM, Gil EG, Gibson PG, Heaney LG, Hew M, Hilberg O, Hoyte F, Jackson DJ, Koh MS, Ko HB, Lee JH, Lehmann S, Chaves Loureiro C, Lúðvíksdóttir D, Menzies-Gow AN, Mitchell P, Papaioannou AI, Popov TA, Porsbjerg CM, Salameh L, Sirena C, Taillé C, Taube C, Tohda Y, Wechsler ME, Price DB. Pfeffer PE, et al. Among authors: munoz esquerre m. Allergy. 2023 Mar 17. doi: 10.1111/all.15711. Online ahead of print. Allergy. 2023. PMID: 36929509
15 results